Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05716659

EEG/MECG/EMG Evaluating the Severity of Aortic Stenosis, Heart Failure and Ischemic Stroke Through an Artificial Intelligenceassisted System.

Conditions: CVD

Sex: All
Ages: 20 Years – N/A
Healthy volunteers: 1
Enrollment: 750
Sponsor: National Taiwan University Hospital

Location: Taiwan

Summary

The specific objectives and methods of this project are: (1) To test the feasibility and accuracy of integrating EEG, MECG and EMG for detecting the severity of diseases such as aortic stenosis, heart failure and ischemic stroke. (2) Improve the accuracy of this multi-channel brain-heart-muscle device by using an artificial intelligence auxiliary system. (3) Provide tailor-made interdisciplinary treatment strategies for patients with different disease states.

Eligibility Criteria

Inclusion criteriaAge≥20 year-oldHealthy subjects or patients with A. Metabolic syndrome (MetS) ;B. HF with reduced ejection fractions (HFrEF, defined by left ventricular ejection fraction≤40%) and current or previous symptoms of HF;C. Severe aortic stenosis (defined aortic valve area < 1.0 cm2 or mean pressure gradient ≥ 40 mmHg), preparing to receive transcatheter aortic valve replacement ;D. Acute ischemic stroke and admitted to stroke intensive care unit (ICU), within 24 hours after onsetThe criteria of MetS includes:Abdominal obesity: waist circumference (for Asians) ≥ 90 cm in men and ≥ 80 cm in women;Hyperglycemia: serum fasting glucose level ≥ 100 mg/dl, or receiving drug treatment for elevated blood sugar;Reduced high-density lipoprotein cholesterol (HDL-C): serum HDL-C < 40 mg/dl in men and < 50 mg/dl in women or on cholesterol drug treatment;Elevated triglycerides: serum triglyceride ≥ 150 mg/dl or on drug treatment of hypertriglyceridemia;Hypertension: systolic blood pressure ≥ 130 mmHg, diastolic blood pressure ≥ 85 mmHg, or on antihypertensive drug treatment.Exclusion criteria:Under treatment for malignancyCurrently receiving immunosuppressantsModified Rankin Scale (mRS) ≥2 prior to the strokeSymptomatic HF in patients with acute ischemic strokeUnable to perform neurocognitive function testUnable to evaluate the physical activity using questionnaire or 6-minute walk testUnable to cooperate with examinations using 3E combo machine.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05716659). StuddyBuddy aggregates publicly available trial information.